Laryngeal Mask in Morbid Obesity

Status Withdrawn

Clinical Trial Summary

Investigators study the performance of both masks, Proseal Laryngeal Mask Airway (PLMA) and I-gel, as temporary ventilatory supraglottic airway devices (SGDs) before tracheal intubation in morbidly obese patients. Data are lacking in such population of patients

Clinical Trial Description

The available data regarding SGDs in morbidly obese patients have focused mainly on PLMA. In general, SGDs have been successfully used as temporary ventilatory devices before laryngoscope-guided tracheal intubation, conduits for endotracheal tube insertion, and primary airway devices during surgery. Second-generation SGDs are preferred for both rescue airway and routine use, compared with first-generation, non-gastric access devices. Data on comparison PLMA vs. I-gel in morbidly obese patient are lacking. The PLMA is a second generation gastric access SGD. PLMA is composed of an airway tube that connects to a mask which, after insertion through the patient's mouth and inflation of cuff, forms an airtight seal on top the glottis allowing a secure airway to be managed by a health care provider. PLMA can be autoclaved and reused many times. I-gel is a new type of single use, second generation, gastric access SGD and doesn't have an inflatable cuff. Because of its thermoplastic elastomer structure, it exactly adapts to the supraglottic tissue by binding with body temperature, thus minimising air leakage. The aim of this study is to compare PLMA and I-gel regarding insertion success rate, the time of insertion, gastric access tube positioning, oropharyngeal leak pressure, assessment of position by fiberoptic, ventilatory parameters and hemodynamic, and complications for each device placed before tracheal intubation in morbidly obese patients. This study is conducted at University Medical Hospital of Padova, with approval from Hospital research Ethical Committee and written informed consents from patients,. Patients are randomly allocated into 2 equal groups, according to the inclusion and exclusion criteria. PLMA (n=35) in which PLMA is used for ventilation. I-gel (n=35) in which I-gel is used for ventilation. I ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04243564
Study type	Interventional
Source	University of Padova
Contact
Status	Withdrawn
Phase	N/A
Start date	February 15, 2021
Completion date	June 15, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03657927` - A Comparison of McGrath MAC Versus C-MAC Videolaryngoscopes in Morbidly Obese Patients	N/A
Recruiting	`NCT04934826` - Comparison of the Absorption of Hydrolyzed or Intact Proteins in Morbid Obese Patients After the Roux Y Gastric Bypass	N/A
Completed	`NCT03181347` - The Microbiology of Bariatric Surgery	N/A
Completed	`NCT03886870` - Obesity, Lifestyle and Work Intervention	N/A
Active, not recruiting	`NCT04433338` - The PREBA Study: Effect of Preoperative Weight Loss With a 14-day Low-calorie Diet on Surgical Procedure and Outcomes in Patients Undergoing RYGB Surgery	N/A
Completed	`NCT03553849` - Utilization of Very Low Calorie Diet in Obese General Surgery Patients	N/A
Completed	`NCT05854875` - Diabetes Remission After RYGBP and RYGBP With Fundus Resection	N/A
Not yet recruiting	`NCT03203161` - Registry on Obesity Surgery in Adolescents
Not yet recruiting	`NCT03601273` - Bariatric Embolization Trial for the Obese Nonsurgical	Phase 1
Active, not recruiting	`NCT02545647` - Banded Versus Non-banded Roux-en-y Gastric Bypass	N/A
Recruiting	`NCT02129296` - Intragastric Balloon, Air Versus Fluid Filled: Randomized Prospective Study	Phase 1/Phase 2
Active, not recruiting	`NCT01564732` - Multicenter Prospective Randomized Controlled Trial of Plicated Laparoscopic Adjustable Gastric Banding	N/A
Completed	`NCT02033265` - Ultrasound-Guided Axillary Brachial Plexus Block: Influence of Obesity
Not yet recruiting	`NCT01652105` - Randomized Trial of Preoperative Diets Before Bariatric Surgery	N/A
Completed	`NCT01963637` - Gastric Volumetry by Gastric Tomodensitometry With Gas	N/A
Completed	`NCT01955993` - Fentanyl Metabolism in Obese Adolescents	N/A
Terminated	`NCT01759550` - Prospective Case-Series of Ligasure Advance Pistol Grip and LigaSure Blunt Tip
Completed	`NCT01149512` - Outcomes of the Adjustable Gastric Band in a Publicly Funded Obesity Program	N/A
Recruiting	`NCT01685177` - Single Anastomosis Duodeno-Ileal Bypass vs Standard Duodenal Switch as a Second Step After Sleeve Gastrectomy in the Super-Morbid Obese Patient	N/A
Terminated	`NCT01041261` - Effects of a Novel Dietary Intervention on Body Composition After Laparoscopic Gastric Bypass Surgery	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.